Literature DB >> 2157863

Immunosuppressive function of hepatitis B antigens in vitro: role of endoribonuclease V as one potential trans inactivator for cytokines in macrophages and human hepatoma cells.

C Jochum1, R Voth, S Rossol, K H Meyer zum Büschenfelde, G Hess, H Will, H C Schröder, R Steffen, W E Müller.   

Abstract

The mRNAs of transiently expressed cytokine genes contain AUUUA-rich sequences in the 3' untranslated regions. In order to examine whether the AU-specific endoribonuclease V (EC 3.1.27.8) described previously by us transinactivates those mRNA species, we introduced a 51-nucleotide ATTTA sequence from tumor necrosis factor into the 3' untranslated region of beta-globin gene. Transcripts of that construct, synthesized in vitro, were prone to endoribonuclease V digestion at those AU-rich sequences. Stimulation of human macrophages with lipopolysaccharide resulted in a shift of the association state of the enzyme from the nuclear matrix-associated to the free form. This shift was strongly prevented by the hepatitis B surface antigen (HBsAg) and more weakly by hepatitis B nucleocapsid antigen and hepatitis B antigen of the X region. HBsAg and, to a lesser extent, hepatitis B nucleocapsid antigen and hepatitis B antigen of the X region inhibited the release of alpha interferon, tumor necrosis factor alpha, and granulocyte-macrophage colony stimulating factor, while it had no effect on interleukin-1 production from stimulated macrophages. Using the human hepatoma cell line PLC/PRF/5, we provide further experimental evidence that endoribonuclease V acts in trans as a posttranscriptional inactivator for nuclear matrix-associated cytokine transcripts. These results suggest that those cytokine transcripts which contain reiterated (overlapping) AUUUA sequences are degraded by nuclear matrix-associated endoribonuclease V. This degradation was comparably high in cells incubated with HBsAg or cells which produced this antigen.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2157863      PMCID: PMC249349          DOI: 10.1128/JVI.64.5.1956-1963.1990

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

Review 1.  The granulocyte-macrophage colony-stimulating factors.

Authors:  D Metcalf
Journal:  Science       Date:  1985-07-05       Impact factor: 47.728

Review 2.  Molecular and cellular pathology of hepatitis B.

Authors:  M A Gerber; S N Thung
Journal:  Lab Invest       Date:  1985-06       Impact factor: 5.662

3.  Monocyte is the main producer of human leukocyte alpha interferons following Sendai virus induction.

Authors:  E Saksela; I Virtanen; T Hovi; D S Secher; K Cantell
Journal:  Prog Med Virol       Date:  1984

4.  Characterization of the major polypeptides of the rat liver nuclear envelope.

Authors:  S H Kaufmann; W Gibson; J H Shaper
Journal:  J Biol Chem       Date:  1983-02-25       Impact factor: 5.157

5.  Rapid transfer of DNA from agarose gels to nylon membranes.

Authors:  K C Reed; D A Mann
Journal:  Nucleic Acids Res       Date:  1985-10-25       Impact factor: 16.971

6.  Structural relationship of human interferon alpha genes and pseudogenes.

Authors:  K Henco; J Brosius; A Fujisawa; J I Fujisawa; J R Haynes; J Hochstadt; T Kovacic; M Pasek; A Schamböck; J Schmid
Journal:  J Mol Biol       Date:  1985-09-20       Impact factor: 5.469

7.  Nucleotide sequence of human monocyte interleukin 1 precursor cDNA.

Authors:  P E Auron; A C Webb; L J Rosenwasser; S F Mucci; A Rich; S M Wolff; C A Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

8.  Transcription termination occurs within a 1000 base pair region downstream from the poly(A) site of the mouse beta-globin (major) gene.

Authors:  B Citron; E Falck-Pedersen; M Salditt-Georgieff; J E Darnell
Journal:  Nucleic Acids Res       Date:  1984-11-26       Impact factor: 16.971

9.  Control of biologically active interleukin 2 messenger RNA formation in induced human lymphocytes.

Authors:  S Efrat; R Kaempfer
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

10.  Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization.

Authors:  G E Nedwin; S L Naylor; A Y Sakaguchi; D Smith; J Jarrett-Nedwin; D Pennica; D V Goeddel; P W Gray
Journal:  Nucleic Acids Res       Date:  1985-09-11       Impact factor: 16.971

View more
  7 in total

1.  Two distinct regions in the 3' untranslated region of tumor necrosis factor alpha mRNA form complexes with macrophage proteins.

Authors:  Z Hel; E Skamene; D Radzioch
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

2.  Small RNA expression from the oncogenic region of a highly oncogenic strain of herpesvirus saimiri.

Authors:  P Geck; S A Whitaker; M M Medveczky; T J Last; P G Medveczky
Journal:  Virus Genes       Date:  1994-01       Impact factor: 2.332

3.  Potent inhibition of hepatitis B virus production in vitro by modified pyrimidine nucleosides.

Authors:  E Matthes; P Langen; M von Janta-Lipinski; H Will; H C Schröder; H Merz; B E Weiler; W E Müller
Journal:  Antimicrob Agents Chemother       Date:  1990-10       Impact factor: 5.191

4.  Low responsiveness of hepatitis B virus-transgenic mice in antibody response to T-cell-dependent antigen: defect in antigen-presenting activity of dendritic cells.

Authors:  S M Akbar; M Onji; K Inaba; K Yamamura; Y Ohta
Journal:  Immunology       Date:  1993-03       Impact factor: 7.397

5.  Binding of sequence-specific proteins to the adenosine- plus uridine-rich sequences of the murine granulocyte/macrophage colony-stimulating factor mRNA.

Authors:  M Bickel; Y Iwai; D H Pluznik; R B Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

6.  Posttranscriptional clearance of hepatitis B virus RNA by cytotoxic T lymphocyte-activated hepatocytes.

Authors:  L V Tsui; L G Guidotti; T Ishikawa; F V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

7.  Monocytes from chronic HBV patients react in vitro to HBsAg and TLR by producing cytokines irrespective of stage of disease.

Authors:  Arjan Boltjes; Zwier M Groothuismink; Gertine W van Oord; Harry L A Janssen; Andrea M Woltman; André Boonstra
Journal:  PLoS One       Date:  2014-05-13       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.